SNQ translates Taiwan's medical and biotech innovations into verifiable, comparable, and credible quality standards — so genuinely valuable products, services, and technologies can be understood and adopted in larger markets.
Make patient-centered, high-quality care Taiwan's global language.
Make great products the world's adopted standard.
SNQ is built on medical quality, safety, clinical evidence, and expert review. For years it has driven certification across medical services, biotech products, health care, and innovative solutions.
It is not just a mark — it is a system that helps the industry organize evidence, examine processes, and build credibility. Through interdisciplinary expert review and institutionalized selection, SNQ turns excellent outcomes into quality proof the market can understand.
Taiwan has mature clinical practice, medical technology, and biotech innovation. But in international partnership, procurement, and market expansion, capability alone doesn't equal trust. Global markets need not just great products, but clear explanation, stable quality, transparent risk understanding, and comparable evidence.
Taiwan's medical and biotech industries have accumulated outstanding clinical experience, technical R&D, and innovation.
Outcomes must be translated into verifiable, traceable quality evidence through data, real-world use, and expert review.
Only when quality is backed by clear, consistent evidence does it become the basis for collaboration, procurement, and market trust.
SNQ helps healthcare institutions and biotech companies translate their outcomes into judgeable, communicable, and trustworthy quality information through evidence review, international benchmarking, and platform connectivity.
Grounded in clinical data, scientific evidence, and real-world use — proving safety, effectiveness, and service quality that stand up to scrutiny.
Aligns with international quality, governance, and market expectations, helping Taiwan's outcomes reach comparable and communicable standards.
Facing international competition across healthcare and biotechnology, quality cannot stop at claims — it must be grounded in verifiable outcomes, sustainable processes, and the real value delivered to patients and markets.
Treatment efficacy, patient outcomes, and long-term follow-up data — demonstrating medical value against international benchmarks.
Evaluates structural and procedural completeness so quality is reproducible and sustained, not merely present in isolated cases.
Measures value and influence on patients, communities, and the international medical community — building compelling value narratives.
SNQ's next step is to help more Taiwanese healthcare institutions, biotech companies, and health industry teams build a quality foundation the world can understand — moving from strong capability to comparable, communicable, and adoptable outcomes.
Makes safe, effective, trustworthy products and services easier to identify.
Reduces uncertainty in collaboration and procurement through quality and service capability.
Translates Taiwan's outcomes into a quality language the world can compare, communicate, and adopt.
Links healthcare providers, industry, expert reviewers, and partnership opportunities — making certified outcomes the starting point for market entry.
